Atomi Financial Group’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$615K Sell
8,776
-741
-8% -$38.3K 0.02% 677
2026
Q1
$483K Buy
+9,517
New +$444K 0.01% 725
2024
Q3
Sell
-4,684
Closed -$556K 925
2024
Q2
$556K Buy
4,684
+2,573
+122% +$326K 0.04% 360
2024
Q1
$225K Buy
+2,111
New +$213K 0.02% 633

Other funds holding MRNA

Atomi Financial Group's MRNA Position: Q2 2026 in Review

Atomi Financial Group reduced its Moderna (MRNA) stake by 7.8% in Q2 2026, selling an estimated $38.3K and leaving 8,776 shares worth $615K. The position accounts for 0.02% of the portfolio, ranked #677.

Atomi Financial Group first reported a position in MRNA in Q1 2024 and has held it in 4 quarters since. 777 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Atomi Financial Group held 8,776 shares of Moderna worth $615K as of Q2 2026.
  • Atomi Financial Group sold 741 Moderna shares in Q2 2026, an estimated $38.3K.
  • Moderna made up 0.02% of Atomi Financial Group's portfolio in Q2 2026, its #677 holding.
  • Atomi Financial Group first reported a position in Moderna in Q1 2024 and has held it in 4 quarters since.
  • 777 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Atomi Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.